Cerillion Plc (LON:CER)

Avid Bioservices Cash Flow Statement

Financials in millions GBP. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Net Income	14.24	15.26	12.93	9.34	6.43	2.61
Depreciation & Amortization	1.28	1.13	1.67	2.08	2	2.05
Other Amortization	1.05	1.05	0.93	0.91	0.88	0.88
Stock-Based Compensation	0.1	0.15	0.21	0.06	0.11	0.07
Other Operating Activities	-0.72	-0.27	-0.19	-0.19	0.71	-0.09
Change in Accounts Receivable	-1.19	-4.94	-6.47	-1.18	-0.24	-1.41
Change in Accounts Payable	-1.83	-1.19	0.67	1.32	-0.08	2.5
Operating Cash Flow	12.94	11.21	9.75	12.34	9.8	6.61
Operating Cash Flow Growth	53.11%	14.94%	-20.98%	25.87%	48.37%	29.55%
Capital Expenditures	-0.42	-0.21	-0.28	-0.63	-0.3	-0.33
Sale (Purchase) of Intangibles	-1.66	-1.3	-1.15	-0.98	-0.97	-1.11
Investing Cash Flow	-2.08	-1.51	-1.43	-1.61	-1.27	-1.44
Long-Term Debt Repaid	-	-0.89	-0.87	-0.81	-1.37	-1.57
Net Debt Issued (Repaid)	-0.94	-0.89	-0.87	-0.81	-1.37	-1.57
Issuance of Common Stock	0.32	0.27	-	0.12	0	0.2
Repurchase of Common Stock	-1.73	-0.37	-	-0.83	-0.51	-0.74
Common Dividends Paid	-3.9	-3.54	-2.89	-2.24	-1.73	-1.49
Financing Cash Flow	-6.24	-4.54	-3.76	-3.76	-3.61	-3.61
Foreign Exchange Rate Adjustments	-0.02	-0.05	-0.08	0.1	-0.06	-0.02
Net Cash Flow	4.6	5.11	4.49	7.08	4.86	1.54
Free Cash Flow	12.53	11	9.47	11.71	9.5	6.28
Free Cash Flow Growth	49.79%	16.13%	-19.13%	23.28%	51.37%	33.41%
Free Cash Flow Margin	29.72%	25.14%	24.18%	35.79%	36.44%	30.15%
Free Cash Flow Per Share	0.42	0.37	0.32	0.40	0.32	0.21
Cash Interest Paid	0.15	0.11	0.12	0.15	0.16	0.21
Cash Income Tax Paid	4.6	4.25	3	1.75	0.29	0.12
Levered Free Cash Flow	7	9.57	7.6	7.84	6.03	3.56
Unlevered Free Cash Flow	7.09	9.64	7.67	7.93	6.13	3.69
Change in Net Working Capital	4.05	2.69	3.26	0.2	0.29	-0.38

Updated Dec 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.